Atopic dermatitis (AD) is a chronic inflammatory skin disease with high prevalence, especially in children. Current ...

Learn how ultrafine bubble showers can improve eczema symptoms by reducing inflammation and enhancing skin barrier proteins.

Researchers examined the risk for serious infection among patients with atopic dermatitis treated with Janus kinase inhibitors vs Th2 cytokine inhibitors.

ATOPIC dermatitis (AD) is the most common chronic inflammatory skin condition, affecting up to 10% of adults and up to 20% of ...

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

Discover a study that investigated how understanding atopic dermatitis endotypes is crucial for advancing personalised ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Opens in a new tab or window ORLANDO -- A novel therapy for atopic dermatitis (AD ... and OX40R-positive T cells release pro-inflammatory cytokines that drive memory responses in AD.

PFIZER, a global biopharmaceutical company, today announced the availability of Cibinqo (abrocitinib) and Staquis (crisaborole) as new additions to the atopic dermatitis treatment spectrum in Malaysia ...

Atopic dermatitis, characterised by persistent itch and recurrent ... is designed to inhibit signalling of the neuroimmune cytokine interleukin-31, which drives itch and is involved in inflammation ...

Asthma and atopic dermatitis are chronic inflammatory diseases of the airways and the skin, respectively, which affect hundreds of millions of children and adults globally. Most patients with asthma ...